OTCMKTS:TEAR - TearLab Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding TearLab Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.04 +0.00 (+6.25 %) (As of 02/18/2020 04:00 PM ET) Add Compare Today's Range$0.04Now: $0.04▼$0.0550-Day Range$0.04MA: $0.04▼$0.0552-Week Range$0.03Now: $0.04▼$0.15Volume8,500 shsAverage Volume43,614 shsMarket Capitalization$533,842.50P/E RatioN/ADividend YieldN/ABeta0.69 ProfileAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TEAR Previous SymbolNASDAQ:TEAR CUSIPN/A CIK1299139 Webhttp://www.tearlab.com/ Phone858-455-6006Debt Debt-to-Equity RatioN/A Current Ratio0.46 Quick Ratio0.36Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$25 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value($1.83) per share Price / Book-0.02Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-2,250,000.00 Net Margins-20.63% Return on EquityN/A Return on Assets-30.88%Miscellaneous Employees34 Outstanding Shares12,561,000Market Cap$533,842.50 Next Earnings Date3/19/2020 (Estimated) OptionableNot Optionable Receive TEAR News and Ratings via Email Sign-up to receive the latest news and ratings for TEAR and its competitors with MarketBeat's FREE daily newsletter. OTC:TEAR Rates by TradingView TearLab (OTCMKTS:TEAR) Frequently Asked Questions What is TearLab's stock symbol? TearLab trades on the OTCMKTS under the ticker symbol "TEAR." When did TearLab's stock split? How did TearLab's stock split work? TearLab's stock reverse split on the morning of Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 23rd 2017. An investor that had 100 shares of TearLab stock prior to the reverse split would have 10 shares after the split. How were TearLab's earnings last quarter? TearLab Corp (OTCMKTS:TEAR) announced its quarterly earnings results on Thursday, August, 8th. The medical research company reported ($0.10) EPS for the quarter. The medical research company earned $5.85 million during the quarter. View TearLab's Earnings History. When is TearLab's next earnings date? TearLab is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for TearLab. Has TearLab been receiving favorable news coverage? News stories about TEAR stock have been trending extremely negative this week, InfoTrie reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. TearLab earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for TearLab. Who are some of TearLab's key competitors? Some companies that are related to TearLab include Sintx Technologies (SINT), United American Healthcare (UAHC), Hypertension Diagnostics (HDII), Calmare Therapeutics (CTTC), Lombard Medical (EVARF), Oncologix Tech (OCLG), Prourocare Medical (PUMD), Quantrx Biomedical (QTXB), Revolutions Medical (RMCP), Scivanta Medical (SCVM) and Viatar CTC Solutions (VRTT). What other stocks do shareholders of TearLab own? Based on aggregate information from My MarketBeat watchlists, some companies that other TearLab investors own include Vertex Energy (VTNR), NovaBay Pharmaceuticals (NBY), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Protalix Biotherapeutics (PLX), Immunomedics (IMMU), Verastem (VSTM), Biocept (BIOC), Corbus Pharmaceuticals (CRBP) and Gilead Sciences (GILD). Who are TearLab's key executives? TearLab's management team includes the folowing people: Mr. Elias Vamvakas, Exec. Chairman & Sec. (Age 60)Mr. Joseph S. Jensen, CEO & Director (Age 47)Mr. Michael Marquez, Chief Financial Officer (Age 37)Dr. Benjamin Sullivan Ph.D., Chief Scientific Officer (Age 43)Mr. Sam Fakhoury, VP of Quality, Compliance & Supply Chain How do I buy shares of TearLab? Shares of TEAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is TearLab's stock price today? One share of TEAR stock can currently be purchased for approximately $0.04. How big of a company is TearLab? TearLab has a market capitalization of $533,842.50 and generates $25 million in revenue each year. TearLab employs 34 workers across the globe.View Additional Information About TearLab. What is TearLab's official website? The official website for TearLab is http://www.tearlab.com/. How can I contact TearLab? TearLab's mailing address is 150 La Terraza Blvd. Suite 101, Escondido CA, 92025. The medical research company can be reached via phone at 858-455-6006 or via email at [email protected] MarketBeat Community Rating for TearLab (OTCMKTS TEAR)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 364 (Vote Outperform)Underperform Votes: 234 (Vote Underperform)Total Votes: 598MarketBeat's community ratings are surveys of what our community members think about TearLab and other stocks. Vote "Outperform" if you believe TEAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TEAR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: How to calculate compound interest
